By Asmita - May 22, 2025
Malaria research at Harvard University introduces a novel strategy of treating mosquitoes with anti-malarial drugs to halt disease transmission, offering a promising alternative to traditional insecticide-treated bed nets. The approach involves using stable drugs absorbed by mosquitoes through their legs to target and eliminate the malaria parasite they carry. Laboratory studies show efficacy, with field trials planned in Ethiopia to evaluate real-world impact and potential as a dual protection measure in global malaria eradication efforts.
istock via Kwangmoozaa
LATEST
Malaria continues to claim over half a million lives annually, mostly among children, with female mosquitoes acting as the primary vectors during their nighttime blood-feeding. Traditional prevention relies heavily on insecticide-treated bed nets, which serve both as a physical barrier and a delivery system for chemicals that kill mosquitoes on contact. However, the effectiveness of these nets is waning as mosquitoes develop resistance to insecticides, prompting scientists to search for innovative approaches.
A research team at Harvard University has pioneered a novel strategy: instead of killing mosquitoes, they propose treating the insects themselves for malaria. By analyzing malaria’s genetic material, the team identified two potent drugs that, when absorbed through mosquitoes’ legs, can eliminate the malaria parasite from the insects. These drugs were tested on materials resembling bed nets, and results showed that infected mosquitoes landing on these surfaces were cured of their infections, thereby halting disease transmission.
The key to this approach lies in the use of a new class of anti-malarial drugs called endochin-like quinolones (ELQs). These compounds remain stable and effective for long periods, even in mosquitoes that have developed resistance to traditional insecticides. When mosquitoes come into contact with ELQ-treated nets, they absorb the drug through their legs, which then kills the malaria parasites they carry. This method targets the parasite directly, reducing the likelihood of resistance developing in the parasite population due to the small number of parasites present in each mosquito.
Laboratory studies have validated the efficacy of this approach, and field trials are planned in Ethiopia to assess real-world impact. The ultimate vision is to combine anti-malarial drugs with insecticides on bed nets, offering dual protection: if one method fails, the other can still prevent malaria transmission. This innovative strategy could become a key element in global malaria eradication efforts.